Announce Date | 05/02/2024 |
EPS Normalized Actual | $-0.1 (Beat by $0.18) |
EPS GAAP Actual | $-0.1 (Beat by $0.18) |
Revenue Actual | $0.417205B |
Revenue Surprise | Beat by $417.205M |
Announce Date | 07/01/2024 (Pre-Market) |
EPS Normalized Estimate | $0.029327 |
EPS GAAP Estimate | $0.029327 |
Revenue Estimate | $1.10438115B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 3.46667 | 11.48 | 3.29164 | 3.68969 | 6 |
Dec 2027 | 2.3425 | 16.99 | 2.22423 | 2.4932 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | -1.14 | -1.14 | 0.417205B | 25.15% | 417.21M |
FQ4 2021 (Dec 2021) | -0.814708 | -0.814708 | 0.473325B | 31.92% | 473.33M |
FQ3 2021 (Sep 2021) | -1.35 | -1.35 | 0.212819B | 37.58% | 212.82M |
FQ2 2021 (Jun 2021) | -0.76 | -0.76 | 0.297605B | 76.17% | 297.61M |
FQ1 2021 (Mar 2021) | -0.87 | -0.87 | 0.312276B | 100% | 312.28M |
FQ4 2020 (Dec 2020) | -0.748525 | -0.748525 | 0.322223B | 59.37% | 322.22M |
FQ3 2020 (Sep 2020) | -0.98 | -0.98 | 0.132836B | 49.55% | 132.84M |
FQ2 2020 (Jun 2020) | -0.55 | -0.55 | 0.070931B | 19.09% | 70.93M |
FQ4 Announce Date
07/01/2024 (Pre-Market)
Consensus EPS Estimates
0.029327
Consensus Revenue Estimates
1.10438115B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | -0.017031 | -- | -0.01837862 | -0.01564027 | 9 |
FQ3 2026 (Jul 2026) | 0.46873 | -- | 0.43045 | 0.50582 | 9 |
FQ2 2026 (Jun 2026) | 0.46873 | -- | 0.43305 | 0.49401 | 5 |
FQ1 2026 (Mar 2026) | 0.063524 | -- | 0.05868791 | 0.06695033 | 11 |
FQ4 2025 (Oct 2025) | -0.20715 | -- | -0.22354 | -0.19023 | 7 |
FQ3 2025 (Jul 2025) | 0.21979 | -- | 0.20184 | 0.23718 | 7 |
FQ2 2025 (Jun 2025) | 0.22235 | -- | 0.20542 | 0.23434 | 10 |
FQ1 2025 (Mar 2025) | -0.12913 | -- | -0.13609 | -0.1193 | 9 |
FQ4 2024 (Oct 2024) | -0.2851 | -- | -0.32189 | -0.16554 | 15 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 1.5B | -- | 1.41B | 1.59B | 8 |
FQ3 2026 (Jul 2026) | 1.61B | -- | 1.5B | 1.7B | 13 |
FQ2 2026 (Jun 2026) | 1.61B | -- | 1.51B | 1.67B | 8 |
FQ1 2026 (Mar 2026) | 1.69B | -- | 1.59B | 1.76B | 10 |
FQ4 2025 (Oct 2025) | 1.24B | -- | 1.16B | 1.32B | 7 |
FQ3 2025 (Jul 2025) | 1.31B | -- | 1.22B | 1.39B | 8 |
FQ2 2025 (Jun 2025) | 1.3B | -- | 1.22B | 1.35B | 7 |
FQ1 2025 (Mar 2025) | 1.35B | -- | 1.28B | 1.41B | 9 |
FQ4 2024 (Oct 2024) | 1.02B | -- | 0.99B | 1.05B | 17 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | -1.14 | -1.14 | 100% | |
FQ4 2021 (Dec 2021) | -0.814708 | -0.814708 | 100% | |
FQ3 2021 (Sep 2021) | -1.35 | -1.35 | 100% | |
FQ2 2021 (Jun 2021) | -0.76 | -0.76 | 100% | |
FQ1 2021 (Mar 2021) | -0.87 | -0.87 | 100% | |
FQ4 2020 (Dec 2020) | -0.748525 | -0.748525 | 100% | |
FQ3 2020 (Sep 2020) | -0.98 | -0.98 | 100% | |
FQ2 2020 (Jun 2020) | -0.55 | -0.55 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $0.42B | $417.21M | 100% |
FQ4 2021 (Dec 2021) | $0B | $0.47B | $473.33M | 100% |
FQ3 2021 (Sep 2021) | $0B | $0.21B | $212.82M | 100% |
FQ2 2021 (Jun 2021) | $0B | $0.3B | $297.61M | 100% |
FQ1 2021 (Mar 2021) | $0B | $0.31B | $312.28M | 100% |
FQ4 2020 (Dec 2020) | $0B | $0.32B | $322.22M | 100% |
FQ3 2020 (Sep 2020) | $0B | $0.13B | $132.84M | 100% |
FQ2 2020 (Jun 2020) | $0B | $0.07B | $70.93M | 100% |